Abstract: The invention provides the use of a bioavailable iron compound and a bioavailable zinc compound in a weight ratio of at least 2:1, and at least one B vitamin, in the manufacture of an edible composition, for use in aiding the cognitive development or cognitive performance of humans having an age of up to 18 years.
FH
| # | Name | Date |
|---|---|---|
| 1 | 1297-MUMNP-2007- CHALLAN.pdf | 2022-03-10 |
| 1 | 1297-MUMNP-2007-CORRESPONDENCE-(12-10-2007).pdf | 2007-10-12 |
| 2 | 1297-MUMNP-2007-FORM 1(18-10-2007).pdf | 2007-10-18 |
| 2 | 1297-MUMNP-2007-AbandonedLetter.pdf | 2018-08-09 |
| 3 | 1297-MUMNP-2007-ABSTRACT-(24-8-2007).pdf | 2018-08-09 |
| 3 | 1297-MUMNP-2007- CORRESPONDENCE (12-07-2010).pdf | 2010-07-12 |
| 4 | 1297-MUMNP-2007-CBR COPY(IPO)-22102016.pdf | 2018-08-09 |
| 4 | 1297-MUMNP-2007- FORM 3 (03-08-2010).pdf | 2010-08-03 |
| 5 | 1297-MUMNP-2007-GENERAL POWER OF ATTORNEY(24-8-2007).pdf | 2018-08-09 |
| 5 | 1297-MUMNP-2007-CLAIMS-(24-8-2007).pdf | 2018-08-09 |
| 6 | 1297-MUMNP-2007-FORM 5(24-8-2007).pdf | 2018-08-09 |
| 6 | 1297-MUMNP-2007-DESCRIPTION(COMPLETE)-(24-8-2007).pdf | 2018-08-09 |
| 7 | 1297-MUMNP-2007-FORM 3(8-8-2012).pdf | 2018-08-09 |
| 7 | 1297-MUMNP-2007-FER.pdf | 2018-08-09 |
| 8 | 1297-MUMNP-2007-FORM 3(24-8-2007).pdf | 2018-08-09 |
| 8 | 1297-MUMNP-2007-FORM 1(24-8-2007).pdf | 2018-08-09 |
| 9 | 1297-MUMNP-2007-FORM 3(24-2-2010).pdf | 2018-08-09 |
| 9 | 1297-MUMNP-2007-FORM 18(24-8-2007).pdf | 2018-08-09 |
| 10 | 1297-MUMNP-2007-FORM 2(COMPLETE)-(24-8-2007).pdf | 2018-08-09 |
| 10 | 1297-MUMNP-2007-FORM 3(18-2-2011).pdf | 2018-08-09 |
| 11 | 1297-MUMNP-2007-FORM 2(TITLE PAGE)-(24-8-2007).pdf | 2018-08-09 |
| 11 | 1297-MUMNP-2007-FORM 3(16-8-2011).pdf | 2018-08-09 |
| 12 | 1297-MUMNP-2007-FORM 3(13-2-2012).pdf | 2018-08-09 |
| 13 | 1297-MUMNP-2007-FORM 2(TITLE PAGE)-(24-8-2007).pdf | 2018-08-09 |
| 13 | 1297-MUMNP-2007-FORM 3(16-8-2011).pdf | 2018-08-09 |
| 14 | 1297-MUMNP-2007-FORM 2(COMPLETE)-(24-8-2007).pdf | 2018-08-09 |
| 14 | 1297-MUMNP-2007-FORM 3(18-2-2011).pdf | 2018-08-09 |
| 15 | 1297-MUMNP-2007-FORM 18(24-8-2007).pdf | 2018-08-09 |
| 15 | 1297-MUMNP-2007-FORM 3(24-2-2010).pdf | 2018-08-09 |
| 16 | 1297-MUMNP-2007-FORM 1(24-8-2007).pdf | 2018-08-09 |
| 16 | 1297-MUMNP-2007-FORM 3(24-8-2007).pdf | 2018-08-09 |
| 17 | 1297-MUMNP-2007-FER.pdf | 2018-08-09 |
| 17 | 1297-MUMNP-2007-FORM 3(8-8-2012).pdf | 2018-08-09 |
| 18 | 1297-MUMNP-2007-DESCRIPTION(COMPLETE)-(24-8-2007).pdf | 2018-08-09 |
| 18 | 1297-MUMNP-2007-FORM 5(24-8-2007).pdf | 2018-08-09 |
| 19 | 1297-MUMNP-2007-CLAIMS-(24-8-2007).pdf | 2018-08-09 |
| 19 | 1297-MUMNP-2007-GENERAL POWER OF ATTORNEY(24-8-2007).pdf | 2018-08-09 |
| 20 | 1297-MUMNP-2007-CBR COPY(IPO)-22102016.pdf | 2018-08-09 |
| 20 | 1297-MUMNP-2007- FORM 3 (03-08-2010).pdf | 2010-08-03 |
| 21 | 1297-MUMNP-2007-ABSTRACT-(24-8-2007).pdf | 2018-08-09 |
| 21 | 1297-MUMNP-2007- CORRESPONDENCE (12-07-2010).pdf | 2010-07-12 |
| 22 | 1297-MUMNP-2007-FORM 1(18-10-2007).pdf | 2007-10-18 |
| 22 | 1297-MUMNP-2007-AbandonedLetter.pdf | 2018-08-09 |
| 23 | 1297-MUMNP-2007-CORRESPONDENCE-(12-10-2007).pdf | 2007-10-12 |
| 23 | 1297-MUMNP-2007- CHALLAN.pdf | 2022-03-10 |
| 1 | 1297mumnp2007_06-03-2017.pdf |